Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: The effect of a treatment switch to integrase Strand transfer inhibitor–based regimens on weight gain and other metabolic syndrome-related conditions

Fig. 1

Weight gain following the switch to INSTI-based regimens. Results are presented as mean values ± standard error. Weight gain in study vs. control group (A), stratified by ethnicity (B), gender (C) and age (D). Differences in weight (kg) were calculated after 12 and 24 months of follow-up; P-values in each panel related to the difference between the control and study groups at 24 months; NS: not significant. Models were adjusted for CD4 and BMI at index time

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us